Cargando…
Bacterial coinfections and secondary infections in COVID-19 patients from a tertiary care hospital of northern India: Time to adhere to culture-based practices
Objective: Bacterial co-pathogens are common in various viral respiratory tract infections, leading to increased disease severity and mortality. Still, they are understudied during large outbreaks and pandemics. This study was conducted to highlight the overall burden of these infections in COVID-19...
Autores principales: | Sharma, Bhawna, Sreenivasan, Priya, Biswal, Manisha, Mahajan, Varun, Suri, Vikas, Singh Sehgal, Inderpaul, Ray, Pallab, Dutt Puri, Goverdhan, Bhalla, Ashish, Narayana Yaddanapudi, Lakshmi, Koushal, Vipin, Angrup, Archana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HBKU Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555674/ https://www.ncbi.nlm.nih.gov/pubmed/34745914 http://dx.doi.org/10.5339/qmj.2021.62 |
Ejemplares similares
-
Emerging Bacterial Pathogens in the COVID-19 Era:
Chryseobacterium gleum
—A Case in Point
por: Angrup, Archana, et al.
Publicado: (2022) -
Safety of an immunomodulator Mycobacterium w in COVID-19
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020) -
Factors affecting decontamination of N95 masks for reuse: Feasibility & practicality of various methods
por: Kanaujia, Rimjhim, et al.
Publicado: (2021) -
In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era
por: Sreenivasan, Priya, et al.
Publicado: (2022) -
High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)